Suchergebnisse - "Biard, Lucie"

PubPharm (9)

1

Effectiveness and safety of rituximab in Takayasu arteritis : a multicenter retrospective study

enthalten in: Joint bone spine | 2024

von Mekinian, A. | Noé, L. | Salvarani, C. | +11

2

Correspondence on 'Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases'

enthalten in: Annals of the rheumatic diseases | 2023

von Boleto, G. | El Chamieh, C. | Biard, L. | +7

CommentOn: Ann Rheum Dis. 2019 Oct;78(10):1405-1411. - PMID 31278138

3

Mental health symptoms are not correlated with peripheral inflammatory biomarkers concentrations in COVID-19-ARDS survivors

enthalten in: Intensive care medicine | 2023

von Chean, D. | Benarroch, S. | Pochard, F. | +28

CommentOn: JAMA. 2022 Mar 15;327(11):1042-1050. - PMID 35179564

4

Direct oral anticoagulant for venous thrombosis in Behçet's syndrome

enthalten in: Autoimmunity reviews | 2021

von Vautier, M. | Gallien, Y. | Emmi, G. | +10

5

Cytokine profile as a prognostic tool in coronavirus disease 2019. Comment on "Urgent avenues in the treatment of COVID-19 : Targeting downstream inflammation to prevent catastrophic syndrome" by Quartuccio et al. Joint Bone Spine. 2020;87:191-93

enthalten in: Joint bone spine | 2021

von Vieira, M. | Maalouf, G. | Hasan, M. | +13

CommentOn: Joint Bone Spine. 2020 May;87(3):191-193. - PMID 32321634

6

Neutrophil-Platelet and Monocyte-Platelet Aggregates in COVID-19 Patients

enthalten in: Thrombosis and haemostasis | 2020

von Le Joncour, A. | Biard, L. | Vautier, M. | +14

CommentOn: Am J Respir Crit Care Med. 2018 Jun 15;197(12):1575-1585. - PMID 29782179

7

Long-Term Outcome and Prognosis Factors of Isolated Aortitis

enthalten in: Circulation | 2020

von Ferfar, Y. | Morinet, S. | Espitia, O. | +15

8

Infectious disease consultation for candidaemia

enthalten in: The Lancet. Infectious diseases | 2020

von Lambert, J. | von Cube, M. | Biard, L. | +2

CommentOn: Lancet Infect Dis. 2019 Dec;19(12):1336-1344. - PMID 31562024

9

Brentuximab vedotin as a bridge to allogeneic stem-cell transplantation for refractory or relapsing patients with CD30 positive anaplastic or T-cell non-Hodgkin lymphomas : a study on behalf of the SFGM-TC

enthalten in: Leukemia & lymphoma | 2019

von Garciaz, S. | Loschi, M. | De Masson, A. | +16

1
[1]